Health Care · Biological Products, (No Diagnostic Substances) · Nasdaq · CIK 1000694 · FYE Dec 31 · Prices AT CLOSE 2026-08-19 (USD) Last $8.79 · Day +10.84% · Mkt cap $1.3B · P/E (FY) 3.1× · 1Y −7.7% · Off 52W high −26.6% · Vol (1Y) 65.5% Price2023-08-21 → 2026-08-19 NVAX close: $8.1 on 2023-08-21 to $8.8 on 2026-08-19. Split-adj closes · 240 of 5,309 · price returnⓘ At a glance | Short interest27.7% of sh out | | Days to cover16.6d | | 13F net flow (QoQ)−3.24% | | Top-10 13F concentration69.1% | | Next report (est.)2026-11-06 |
SI 2026-07-31 · 13F 2026-Q1ⓘ Key fundamentalsFY 2025 | P/E (FY)3.1× | | Sales (TTM)$413.8M | | Earnings (TTM)-$247.7M | | Net margin39.2% | | Sales growth 3Y−17.2% |
FY ratios · TTM sales/earnings (USD)ⓘ Trailing returns | YTD+30.8% | | 1Y−7.7% | | 3Y+8.9% | | 5Y−96.0% | | 10Y−93.7% | | Since incept. (ann.)−3.8% |
Total return · from 2005-07-11ⓘ Risk | Ann. volatility (1Y)65.5% | | Ann. volatility (3Y)102.0% | | Sharpe (1Y)0.16 | | Sharpe (3Y)0.51 | | Max drawdown (1Y)−35.9% | | Max drawdown (3Y)−74.1% | | Beta (3Y vs SPY)2.99 |
Daily returns, ann.ⓘ Top institutional holders13F 2026-Q1 | Manager | Shares | Value | % sh out | QoQ |
|---|
| SHAH CAPITAL MANAGEMENT | 14.8M | $121M | 9.11% | +2.0% | | BlackRock, Inc. | 12.8M | $105M | 7.88% | −0.4% | | STATE STREET CORP | 9.0M | $73M | 5.51% | −5.8% | | D. E. Shaw & Co., Inc. | 7.7M | $63M | 4.73% | +28.7% | | VANGUARD PORTFOLIO MANAGEMENT LLC | 7.2M | $58M | 4.39% | new | | VANGUARD CAPITAL MANAGEMENT LLC | 7.1M | $58M | 4.38% | new | | Sanofi | 6.9M | $56M | 4.22% | +0.0% | | BANK OF AMERICA CORP /DE/ | 6.6M | $54M | 4.07% | −19.9% |
Δ vs 2025-Q4ⓘ Latest reported quarterslast report 2026-08-06 | Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|
| 2026-06-30 | 2026-08-06 | −$0.32 | −151.6% | $56.7M | −76.3% | | 2026-03-31 | 2026-05-06 | −$0.06 | −102.0% | $139.5M | −79.1% | | 2025-12-31 | 2026-02-26 | — | — | $147.1M | +66.6% | | 2025-09-30 | 2025-11-06 | −$1.25 | — | $70.4M | −16.6% |
As-reported XBRL · next 2026-11-06 est.ⓘ Segment mixFY2025 (ended Dec 2025) Reportable 100% business · TAGGED revenueⓘ Basis & disclosures - EOD closes · nothing imputed or averaged · absent “—”
- As-of differs by block · 13F = US long, 45+d lag, LOWER bound
- Not investment advice · no recommendation, price target or solicitation
- EDGAR + foreign registers · marketstack (licensed EOD) · spzco.com/methodology
| 
